Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

New leader at NDO Surgical: Bernard Haffey assumes the helm of NDO Surgical as CEO, effective April 10. Haffey will help elevate commercial adoption of and improve reimbursement for NDO's Plicator endoscopic suturing technology for the treatment of gastroesophageal reflux disease. The new chief will draw on his experience in bringing early-stage medical devices to market, most recently as chief commercial officer at laser vision technology maker IntraLase, which was recently acquired by Advanced Medical Optics (1"The Gray Sheet" Jan 15, 2007, p. 4). Prior to IntraLase, Haffey served as CEO at NeuroVision, as well as executive VP and chief commercial officer at Summit Autonomous, which was acquired by Alcon Laboratories in 2000. NDO Surgical also brings on John Frantzis as VP-global sales and business development. Frantzis carries 25 years high-tech and medical device management experience, most recently as VP-sales and business development at ocular biometric firm Retica. NDO Surgical is conducting animal trials for a sleeve gastroplasty device on the Plicator platform to treat obesity...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel